Dr. Sheeja Pullarkat is interested in understanding the clinicopathologic behavior of hematologic neoplasms such as leukemias and lymphomas based on the chemokine expression. Other areas of interests include molecular pathogenesis of leukemias and myeloid neoplasms such as systemic mastocytosis.
Pullarkat ST, Pullarkat V, Kroft SH, Wilson CS, Ahsanuddin AN, Mann KP, Thein M, Grody WW, Brynes RK. Systemic mastocytosis associated with t(8;21)(q22;q22) acute myeloid leukemia. J Hematop. 2009 Mar;2(1):27-33. Epub 2009 Feb 10.
Pullarkat ST, Danley K, Bernstein L, Brynes RK, Cozen W. High lifetime incidence of adult acute lymphoblastic leukemia among Hispanics in California. Cancer Epidemiol Biomarkers Prev. 2009 Feb;18(2):611-5.
Pullarkat ST, Vardiman JW, Slovak ML, Rao DS, Rao NP, Bedell V, Said JW. Megakaryocytic blast crisis as a presenting manifestation of chronic myeloid leukemia. Leuk Res. 2008 Nov;32(11):1770-5. Epub 2008 Apr 15.
Pullarkat ST, Sedarat F, Paquette R, Said J. Systemic mastocytosis with plasma cell dyscrasia: report of a case. Leuk Res. 2008 Jul;32(7):1160-3. Epub 2007 Dec 3.
Pullarkat VA, Bueso-Ramos C, Lai R, Kroft S, Wilson CS, Pullarkat ST, Bu X, Thein M, Lee M, Brynes RK. Systemic mastocytosis with associated clonal hematological non-mast-cell lineage disease: analysis of clinicopathologic features and activating c-kit mutations. Am J Hematol. 2003 May;73(1):12-7.